• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Is There a Connection Between Hormonal Contraception and Suicide?

Is There a Connection Between Hormonal Contraception and Suicide?

April 1, 2018
Adam Strassberg, MD.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Adam Strassberg, MD. Dr. Strassberg has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Review of: Skovlund CW et al, Am J Psychiatry 2017 Nov 17 appiajp201717060616. [Epub ahead of print]

Clinical evidence is growing regarding an association between hormonal contraception and mood disturbances (Skovlund CW et al, JAMA Psychiatry 2016;73(11):1154–1162), and recently researchers at the University of Copenhagen published a study attempting to correlate hormonal contraceptive use with suicidal thinking and behavior.

From 1996 through 2013, a nationwide prospective cohort study was conducted of women in Denmark with no psychiatric diagnoses, no antidepressant use, and no hormonal contraceptive use prior to age 15. A total of 475,802 women were followed for an average of 8.3 years. Their ages ranged from 15 to 33 (with an average age of 21), and 54% of them were current or recent users of hormonal contraception.

During this same time period, there were 6,999 first suicide attempts and 71 suicides in this population. The risks for suicide attempt and suicide were calculated by comparing women who used hormonal contraception vs those who did not. The relative risk among current and recent users of hormonal contraception was 1.97 for first suicide attempt and 3.08 for completed suicide. All hormonal contraceptive products were considered in the study: patches, vaginal rings, IUDs, depot formulations, progestin-only products, and oral combined products.

Stratified by age, the relative risk of suicide attempt with hormonal contraceptive use was 2.06 for women ages 15–19, 1.61 for ages 20–24, and 1.65 for ages 25–33. Also, the relative risk for a first suicide attempt increased rapidly after initiation of hormonal contraceptive use, peaking after 2 months, and then remaining at least double its initial value until 1 year after initiation.

Stratified by various classes of hormonal contraception products, the relative risks for suicide attempt were 1.91 for oral combined products, 2.29 for oral progestin-only products, 2.58 for the vaginal ring, and 3.28 for the patch.

TCPR’s Take
Suicide and suicide attempts are rare events; however, the enormity of the study population in this analysis allowed for impressive statistical rigor. Also, as mood symptoms are a common reason to stop hormonal contraception use, this study skillfully avoided any such out-selection by including all women prior to their first use of any hormonal contraception.

The results of this study support the hypothesis that hormonal contraception may have a direct influence on the neurobiology of suicidal behavior. Though rare, even with elevated relative risks, these potential side effects of hormonal contraceptive use are clearly significant, and so TCPR recommends informing patients using hormonal contraceptives about these risks. Also, we should observe particular caution in any of our adolescent patients starting oral contraceptives for the first time.
General Psychiatry
KEYWORDS research_updates
    Adam Strassberg, MD.

    Can Mindfulness-Based Stress Reduction Affect Symptom Outcomes in Older Adults?

    More from this author
    www.thecarlatreport.com
    Issue Date: April 1, 2018
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - Neurofeedback, TCPR, April 2018
    Neurofeedback in Psychiatry: What’s the Evidence?
    An Antidepressant Diet
    Lisdexamfetamine for BED: How Effective Over the Long Term?
    Is There a Connection Between Hormonal Contraception and Suicide?
    Is EEG Useful in Psychiatry?
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.